phase II studi weekli infus high-dos fluorouracil leucovorin colorect carcinoma twenty-two patient advanc colorect carcinoma studi patient chemotherapi combin fluorouracil LV patient subcutan port insert portabl extern infus pump outpati treatment LV hour continu infus mean steady-st plasma concentr mumol/l rang mumol/l dose previou phase maximum-toler dose mtd combin fix dose LV treatment weekli twenty-two patient total cours treatment eleven instanc grade toxic diarrhea stomat hand/foot syndrom overal object respons untreat patient respond complet respons CR lung liver metastat site median durat surviv untreat patient month month patient result short-term infusion therapi LV patient advanc metastat colorect cancer accept toxic equival superior surviv untreat patient altern method administr agent 